Medline's Record IPO: Why This 'Boring' Healthcare Giant Could Be a Portfolio Cornerstone
Medline's return to public markets marks a pivotal moment for investors seeking stability and growth. With a dominant position in medical supplies and a history of relentless organic expansion, the company presents a compelling case in an uncertain economic climate.